Desperate people sometimes do desperate things. An 86-year-old man in Florida killed his wife of 50 years earlier this month. The reason he gave? She was suffering and they couldn’t afford her medicine.
This tragedy was preventable. We’ve seen that drug prices for brand name, generic and specialty drugs continue to … Continue to Article-->
By Benjamin Elgin and Robert Langreth
In August 2015, Turing Pharmaceuticals and its then-chief executive, Martin Shkreli, purchased a drug called Daraprim and immediately raised its price more than 5,000 percent. Within days, Turing contacted Patient Services Inc., or PSI, a charity that helps people meet the … Continue to Article-->
By Ed Silverman
Doctors may be encouraged to prescribe lower-cost generics, but a new study found that Americans spent an extra $73 billion between 2010 and 2012 on pricier brand-name drugs because physicians failed to sufficiently recommend these copycat treatments to their patients. And consumers paid nearly … Continue to Article-->
Last week, executives from Valeant Pharmaceuticals testified before the Senate’s Special Committee on Aging during the third in a series of hearings investigating sudden price spikes in drugs that have been around for decades.
During the three-hour hearing, Senate committee members took turns admonishing the execs for … Continue to Article-->
The Globe and Mail
By Eric Reguly
Presidential candidates Hillary Clinton, Bernie Sanders and Donald Trump were outraged last fall when Turing Pharmaceuticals jacked up the price of Daraprim, a drug used to fight parasitic infections often found in AIDS patients, to $750 (all currency in U.S. dollars) a pill from $13.50. … Continue to Article-->